BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 9626806)

  • 21. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T; Farrokhshad K; Brummer E; Stevens DA
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte colony-stimulating factor does not enhance phagocytosis or microbicidal activity of human mature polymorphonuclear neutrophils in vitro.
    Shimono N; Okada K; Takeda D; Eguchi K; Misumi H; Sawae Y; Niho Y
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):556-62. PubMed ID: 8556501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization.
    Klingebiel T; Handgretinger R; Herter M; Eppinger T; Bader P; Lang P; Dopfer R; Scheel-Walter H; Haus U; Niethammer D
    J Hematother; 1995 Aug; 4(4):307-14. PubMed ID: 7489145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
    O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
    Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation.
    Fabian I; Kletter Y; Bleiberg I; Gadish M; Naparsteck E; Slavin S
    Exp Hematol; 1991 Oct; 19(9):868-73. PubMed ID: 1716591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
    Natarajan U; Randhawa N; Brummer E; Stevens DA
    J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic management in oncology practice. Part 1. Myeloid growth factors.
    Glaspy JA
    Oncology (Williston Park); 2003 Nov; 17(11):1593-603. PubMed ID: 14682110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients.
    Terashi K; Oka M; Ohdo S; Furukubo T; Ikeda C; Fukuda M; Soda H; Higuchi S; Kohno S
    Antimicrob Agents Chemother; 1999 Jan; 43(1):21-4. PubMed ID: 9869559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
    Haas R; Hohaus S; Egerer G; Ehrhardt R; Witt B; Hunstein W
    Bone Marrow Transplant; 1992 Jun; 9(6):459-65. PubMed ID: 1352717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.
    Kaku K; Takahashi M; Moriyama Y; Nakahata T; Masaoka T; Yoshida Y; Shibata A; Kaneko T; Miwa S
    Leuk Lymphoma; 1993 Oct; 11(3-4):229-38. PubMed ID: 8260897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
    Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
    Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors.
    Hansen PB; Kjaersgaard E; Johnsen HE; Gram J; Pedersen M; Nikolajsen K; Hansen NE
    Br J Haematol; 1993 Sep; 85(1):50-6. PubMed ID: 7504510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital neutropenia: a case study.
    Daghistani D; Jimenez JJ; Toledano SR; Cirocco RE; Yunis AA
    Am J Pediatr Hematol Oncol; 1990; 12(2):210-4. PubMed ID: 1696074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of recombinant human granulocyte colony-stimulating factor on superoxide production by neutrophil in cancer patients receiving chemotherapy].
    Yoshida M; Oshi M; Aso Y; Yanagisawa R; Kishi H; Ishida Y
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1262-8. PubMed ID: 7689123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
    Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
    Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.